Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy.
Hirofumi Yasue(Kumamoto City Hospital), Hiroo Imura(Kyoto University), Hisao Ogawa(Kumamoto University Hospital), Kazuhiro Okumura(Tenri Hospital), Yoshihiko Saito(National Archives and Records Administration), Kazuwa Nakao(Kyoto University), Mitsuro Kurose(Kumamoto University), Michihisa Jougasaki(Kagoshima Medical Center), K Matsuyama, Keisuke Obata(Kyoto University)
Cited by 133
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755